Cargando…

Accumulation and suppressive function of regulatory T cells in malignant ascites: Reducing their suppressive function using arsenic trioxide in vitro

Although adoptive cell therapy (ACT) has demonstrated effective and remarkable clinical responses in several studies, this approach does not lead to objective clinical responses in all cases. The function of ACT is often compromised by various tumor escape mechanisms, including the accumulation of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zilong, Hu, Shidong, Wu, Youjun, Li, Songyan, He, Changzheng, Xing, Xiaowei, Wang, Yufeng, Du, Xiaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840526/ https://www.ncbi.nlm.nih.gov/pubmed/29552182 http://dx.doi.org/10.3892/ol.2018.7974

Ejemplares similares

Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities
por: Hu, Shidong, et al.
Publicado: (2019)

Ammonium and arsenic trioxide are potent facilitators of oligonucleotide function when delivered by gymnosis
por: Zhang, Xiaowei, et al.
Publicado: (2018)

Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites
por: Hrvat, Antonio, et al.
Publicado: (2023)

Arsenic trioxide induces regulatory functions of plasmacytoid dendritic cells through interferon-α inhibition
por: Ye, Yishan, et al.
Publicado: (2020)

Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells
por: Zhang, Lin, et al.
Publicado: (2018)

Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques
por: He, Yizi, et al.
Publicado: (2023)

Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells
por: Wang, Lei, et al.
Publicado: (2016)

Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation
por: Nakamura, Shunsuke, et al.
Publicado: (2013)

miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells
por: Gu, Shiyan, et al.
Publicado: (2017)

Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer
por: Yang, Meng-Hang, et al.
Publicado: (2019)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019)

Treatment Effect of Tuftsin and Antigen Peptide Combined with Immune Cells on Colorectal Cancer
por: Zou, Boyuan, et al.
Publicado: (2019)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis
por: Pan, Chaoyun, et al.
Publicado: (2016)

Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis
por: Zhang, Yong, et al.
Publicado: (2016)

Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021)

CD39(+) regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
por: Ahlmanner, Filip, et al.
Publicado: (2018)

Functional and structural phenotyping of cardiomyocytes in the 3D organization of embryoid bodies exposed to arsenic trioxide
por: Rebuzzini, Paola, et al.
Publicado: (2021)

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
por: Ling, Sunbin, et al.
Publicado: (2017)

Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
por: Wu, Yuni, et al.
Publicado: (2012)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Enhancing an Oxidative “Trojan Horse” Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside
por: Burska, Agata N., et al.
Publicado: (2022)

Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
por: Hu, Jiasheng, et al.
Publicado: (2013)

Bcl‐2 hijacks the arsenic trioxide resistance in SH‐SY5Y cells
por: Wang, Jinling, et al.
Publicado: (2021)

Granzymes are necessary for suppressive function of regulatory T cells
por: Co, Dominic O, et al.
Publicado: (2012)

Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung.
por: Ishinishi, N, et al.
Publicado: (1977)

Mortality experience in relation to a measured arsenic trioxide exposure
por: Pinto, Sherman S., et al.
Publicado: (1977)

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
por: Sertel, Serkan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gce45ffmpafclf96sjq32mkv55